Naturalendo Tech Co., Ltd. (KOSDAQ:168330)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,600.00
0.00 (0.00%)
At close: Apr 23, 2026
Market Cap85.09B +92.6%
Revenue (ttm)22.23B -0.2%
Net Income-3.22B
EPS-102.00
Shares Out31.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume33,895
Average Volume41,903
Open2,595.00
Previous Close2,600.00
Day's Range2,530.00 - 2,625.00
52-Week Range1,862.00 - 6,300.00
Beta0.26
RSI62.61
Earnings DateMay 22, 2026

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a ultimate men’s prostate and uri... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 81
Stock Exchange KOSDAQ
Ticker Symbol 168330
Full Company Profile

Financial Performance

In 2025, Naturalendo Tech's revenue was 22.23 billion, a decrease of -0.16% compared to the previous year's 22.26 billion. Losses were -3.22 billion, -17.10% less than in 2024.

Financial Statements